Could a muscle relaxant ease shingles pain?
NCT ID NCT07378046
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding the muscle relaxant baclofen to standard shingles treatment can better reduce moderate to severe pain. Researchers will enroll 750 adults with shingles rash for less than 90 days. Participants will receive either baclofen plus usual care or usual care alone, and pain levels will be tracked over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Baclofen
- What this could lead to
- If it works, this could offer a new, safe option to ease shingles pain and lower the risk of long-term nerve pain.
- What could go wrong
- This is an early-stage trial without a phase, so results are uncertain. Baclofen may not work better than standard care and can cause side effects like drowsiness or muscle weakness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital, Beijing, Beijing 100070
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?